SAN DIEGO, Calif., Oct. 3, 2016 /PRNewswire/ -- Nasseo, Inc., a medical technology company dedicated to developing enhancedsurface technologies for dental and orthopedic applications, has been awarded a Small Business Innovation Research Grant from the National Science Foundation (NSF).
The NSF grant funding will further Nasseo's work improving spinal implants by
"The National Science Foundation's interest in advancing our work is a distinct honor. The grant will accelerate development of our unique platform surface technology, with an ultimate goal of improving clinical outcomes for orthopedic patient care," says Nasseo's Co-founder and CTO Dr. Garrett Cale Smith, who will also serve as primary investigator on the study. Prior to Nasseo, Smith co-founded Oculeve, Inc., a medical technology company acquired by Allergan PLC.
Nasseo holds four issued patents on nanotube platform technology.
To date, over 10 years of research have validated Nasseo's nanotube surface technology; numerous studies have demonstrated enhanced bone cell response and anti-bacterial properties compared with conventional implant surfaces.
About Nasseo, Inc.Nasseo, Inc. is a privately owned medical device company developing enhanced surface technologies for dental, spinal, and orthopedic applications. Nasseo was founded based on the intellectual property developed at the University of California, San Diego. The Company's TiArray Dental Implant System has received 510(k) clearance. Nasseo is headquartered in San Diego, CA, with research & development facilities in Phoenix, AZ.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/national-science-foundation-funds-nasseo-inc-for-nanotube-technology-on-peek-orthopedic-devices-300337515.html
SOURCE Nasseo, Inc.
Subscribe to our Free Newsletters!
Cyanosis is the bluish or purplish discoloration of the skin and mucus membranes due to lack of ...
Find out about travel shots or vaccination before you travel to your destination country. Travel ...
Hay fever is caused by allergy to pollen and is characterized by runny or blocked nose, sneezing, ...View All